Nieuws

Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
Hims & Hers (NYSE: HIMS) is attracting investors looking to buy the dip in this impressive growth stock. Where to invest ...
De Tijd6d
Wall Street: Tesla trekt robotspurt, Hims & Hers stort in
Het sentiment in New York is positief, ondanks een Iraanse aanval op een Amerikaanse basis in Qatar. Tesla trekt op nu het ...
IEX.nl6d
Novo en Hims & Hers ruziën na mislukken Wegovy-deal
Novo Nordisk beëindigde maandag een kortstondige overeenkomst om het afslankmiddel Wegovy via Hims & Hers Health te verkopen, ...
Hims & Hers CEO No Longer A Billionaire After Novo Nordisk Deal Collapses
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Investing.com5d
CFO Okupe van Hims & Hers verkoopt aandelen ter waarde van $ 1,09 mln.
Oluyemi Okupe, Chief Financial Officer van Hims & Hers Health, Inc. (NYSE: HIMS ), heeft op 23 juni 2025 23.107 gewone aandelen Class A verkocht voor ongeveer $ 1,09 mln. De aandelen werden verkocht ...
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...
Novo, Hims & Hers engage in war of words after Wegovy deal falls apart
Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...
Hims & Hers stock plunges after Novo Nordisk ends its brief partnership
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
Why Hims & Hers Health Stock Is Crashing Today
The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...
Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...